Fulvestrant
Faslodex · ATC code L02BA03
Brand names: Faslodex, Fulvestrant +pharma, Fulvestrant Accord, Fulvestrant Aptapharma, Fulvestrant Ever Pharma, Fulvestrant Ever Valinject, Fulvestrant Ratiopharm, Fulvestrant Ribosepharm, Fulvestrant Sandoz, Fulvestrant Stada, Faslant, Fuxran, Ulvest
- Key facts
- Active substance
- Fulvestrant
- Drug class
- Estrogen antagonist
- ATC code
- L02BA03
- Authorisation
- centrally authorised across the EU (EMA)
- Dosage forms
- Faslodex 250 mg solution for injection.
- Marketing authorisation holder
- AstraZeneca AB
- Information as of
- 2026-10-27
Key facts
Fulvestrant is an oestrogen receptor antagonist (Faslodex) given by intramuscular injection. It is used for hormone receptor-positive, locally advanced or metastatic breast cancer, alone or with palbociclib.
What it is used for
- Monotherapy for estrogen receptor positive, locally advanced or metastatic breast cancer in postmenopausal women
- Without prior endocrine therapy, or with relapse/progression on or after antiestrogen therapy
- With palbociclib for HR-positive, HER2-negative advanced breast cancer after prior endocrine therapy
- Pre- or perimenopausal women on the combination also receive an LHRH agonist
Dosing
- 500 mg at intervals of one month, with an additional 500 mg dose two weeks after the initial dose
- Given as two consecutive 5 ml slow intramuscular injections, one in each buttock
- No dose adjustment in mild to moderate renal or hepatic impairment
- Severe renal impairment (creatinine clearance <30 ml/min): caution
Contraindications
- Hypersensitivity to the active substance or any of the excipients
- Pregnancy and lactation
- Severe hepatic impairment
Important warnings
- Caution in mild to moderate hepatic impairment and severe renal impairment
- Caution in bleeding diatheses, thrombocytopenia or anticoagulant treatment (intramuscular route)
- Thromboembolic events
- Injection site sciatica, neuralgia and peripheral neuropathy; caution at the dorsogluteal site near the sciatic nerve
- Potential risk of osteoporosis; interference with estradiol antibody assays
Side effects
- Most frequent (monotherapy): injection site reactions, asthenia, nausea
- Increased hepatic enzymes (ALT, AST, ALP)
- Thromboembolic events
- Sciatica and peripheral neuropathy
Interactions
- Does not inhibit CYP3A4; no clinically relevant change with rifampicin or ketoconazole
- No dose adjustment needed with CYP3A4 inhibitors or inducers
Pregnancy and breastfeeding
- Contraindicated in pregnancy and lactation
- Effective contraception during treatment and for 2 years after the last dose
Summary of the official product information, written with AI on 2026-10-28. Every number was checked automatically against the original text. Not reviewed by a physician – the full official text is authoritative.
Common questions – ask Medelix
For patients
Package leaflet, verbatim
Authorisation and brand names by country
Medicines with exactly this active-substance composition, as listed in the national registers – alphabetical and without ranking. Whether a product is currently available is not shown here.
EU – centrally authorised (all member states)
- FaslodexAstraZeneca AB · EMEA/H/C/000540
- Fulvestrant Mylan · genericMylan Pharmaceuticals Limited · EMEA/H/C/004649
Source: European Medicines Agency (EMA), product information
Germany
- Fulvestrant1 A Pharma Gmbh, Ever Valinject Gmbh, Ever Neuro Pharma Gmbh, Hikma Farmacêutica (Portugal), S.A., Ratiopharm Gmbh, Medical Valley Invest Ab, Glenmark Arzneimittel Gmbh, Heumann Pharma Gmbh & Co. Generica Kg, Onkovis Gmbh, Zentiva Pharma Gmbh, Accord Healthcare B.V., Cipla Europe Nv, Hexal Ag, Eugia Pharma (Malta) Limited, Stadapharm Gmbh, Betapharm Arzneimittel Gmbh, Aliud Pharma Gmbh · 19 register entries
Source: EMA – Article 57 product data (EU/EEA), as of 2026-10-28
Austria
- Fulvestrant +pharma+pharma Arzneimittel Gmbh · 1 register entry
- Fulvestrant AccordAccord Healthcare B.V. · 1 register entry
- Fulvestrant AptapharmaApta Medica Internacional D.O.O. · 1 register entry
- Fulvestrant Ever PharmaEver Valinject Gmbh · 1 register entry
- Fulvestrant Ever ValinjectEver Valinject Gmbh · 1 register entry
- Fulvestrant RatiopharmTeva B.V · 1 register entry
- Fulvestrant RibosepharmHikma Farmacêutica (Portugal), S.A. · 1 register entry
- Fulvestrant SandozSandoz Gmbh · 1 register entry
- Fulvestrant StadaStada Arzneimittel Gmbh · 1 register entry
Source: EMA – Article 57 product data (EU/EEA), as of 2026-10-28
Turkey
- FaslantDEVA HOLDİNG A.Ş. · 2 register entries
- FaslodexASTRAZENECA İLAÇ SAN. VE TİC. LTD. ŞTİ. · 2 register entries
- FuxranSANDOZ İLAÇ SAN. VE TİC. A.Ş. · 2 register entries
- UlvestTEVA İLAÇ SAN. VE TİC. A.Ş. · 1 register entry
Source: TİTCK – Ruhsatlı Beşeri Tıbbi Ürünler Listesi, as of 2026-10-16
Brand names in 28 more European countries
- Belgium
- Fulvestrant Accord, Fulvestrant Eugia, Fulvestrant Ever Pharma, Fulvestrant Sandoz, Fulvestrant Teva
- Bulgaria
- Fulvestrant Ever Pharma, Fulvestrant Pharmascience, Fulvestrant Sandoz, Васталома, Лабама, Фулвестрант Ever Pharma, Фулвестрант Акорд, Фулвестрант Ромфарм, Фулвестрант Тева
- Croatia
- Fulvestrant Accord, Fulvestrant Aptapharma, Fulvestrant Ever Pharma, Fulvestrant Pliva, Fulvestrant Sandoz
- Cyprus
- Fulvestrant Accord, Fulvestrant Rompharm
- Czechia
- Fulvestrant Accord, Fulvestrant Ever Pharma, Fulvestrant Sandoz, Fulvestrant Stada, Fulvestrant Teva, Fulvestrant Vipharm
- Denmark
- Fulvestrant "stada", Fulvestrant Accord, Fulvestrant Ever Pharma, Fulvestrant Glenmark, Fulvestrant Medical Valley, Fulvestrant Orion, Fulvestrant Reddy, Fulvestrant Stada Nordic
- Estonia
- Fulvestrant Accord, Fulvestrant Aliud, Fulvestrant Sandoz, Fulvestrant Stada, Fulvestrant Zentiva
- Finland
- Fulvestrant Accord, Fulvestrant Ever Pharma, Fulvestrant Orion, Fulvestrant Ratiopharm, Fulvestrant Sandoz, Fulvestrant Stada
- France
- Fulvestrant
- Greece
- Fulvestrant Accord, Fulvestrant Demo, Fulvestrant Innovis
- Hungary
- Fulvestrant Aptapharma, Fulvestrant Elc, Fulvestrant Ever Pharma, Fulvestrant Pharmascience, Fulvestrant Sandoz, Fulvestrant Stada, Fulvestrant Teva, Fulvestrant Vipharm, Fulvesztrant Accord, Imarsa, Vastaloma
- Iceland
- Faslodex, Fulvestrant Accord, Fulvestrant Medical Valley, Fulvestrant Mylan, Fulvestrant Stada, Fulvestrant Teva, Vastaloma
- Ireland
- Fulvestrant Accord Healthcare Ireland, Fulvestrant Ever Pharma, Fulvestrant Reddy Holding, Fulvestrant Rowex, Fulvestrant Teva
- Italy
- Fulvestrant Accord, Fulvestrant Aurobindo, Fulvestrant Dr. Reddy's, Fulvestrant Ever Pharma, Fulvestrant Hikma, Fulvestrant Sandoz, Fulvestrant Zentiva
- Latvia
- Fulvestrant Aliud, Fulvestrant Stada
- Liechtenstein
- Faslodex, Fulvestrant Mylan
- Lithuania
- Fulvestrant Aliud, Fulvestrant Orion, Fulvestrant Sandoz, Fulvestrant Stada, Fulvestrant Teva, Fulvestrant Zentiva
- Luxembourg
- Fulvestrant Teva
- Malta
- Fulvestrant Eugia, Fulvestrant Ever Pharma
- Netherlands
- Fulvestrant, Imarsa, Vastaloma
- Norway
- Faslodex, Fulvestrant Accord, Fulvestrant Ever Pharma, Fulvestrant Medical Valley, Fulvestrant Mylan, Fulvestrant Reddy, Fulvestrant Stada
- Poland
- Fulvestrant Eugia, Fulvestrant Ever Pharma, Fulvestrant Medical Valley, Fulvestrant Reddy, Fulvestrant Sandoz, Fulvestrant Stada Stada, Fulvestrant Sun, Fulvestrant Vipharm, Fulwestrant Accord
- Portugal
- Ambiful, Cykostra, Fulvestrant Accord, Fulvestrant Adalvo, Fulvestrant Cttq, Fulvestrant Generis, Fulvestrant Hexal, Fulvestrant Hikma, Fulvestrant Orion, Fulvestrant Reddy, Fulvestrant Rompharm, Fulvestrant Sandoz
- Romania
- Falvax, Fulvestrant Accord, Fulvestrant Ever Pharma, Fulvestrant Rompharm, Fulvestrant Sun, Fulvestrant Teva, Imarsa
- Slovakia
- Fulvestrant Accord, Fulvestrant Ever Pharma, Fulvestrant Sandoz, Fulvestrant Stada, Fulvestrant Teva, Fulvestrant Vipharm
- Slovenia
- Fulvestrant Accord, Fulvestrant Aptapharma, Fulvestrant Ever Pharma, Fulvestrant Lek, Fulvestrant Teva
- Spain
- Afultrant, Ambiful, Cykostra, Fulvestrant Dr. Reddys, Fulvestrant Eugia, Fulvestrant Hikma, Fulvestrant Stada, Fulvestrant Stadafarma, Fulvestrant Sun, Fulvestrant Teva, Fulvestrant Viso Farmacéutica, Kileza, Onnimia, Strantas
- Sweden
- Fulvestrant Accord, Fulvestrant Ever Pharma, Fulvestrant Glenmark, Fulvestrant Medical Valley, Fulvestrant Orion, Fulvestrant Reddy, Fulvestrant Sandoz, Fulvestrant Stada, Fulvestrant Sun, Fulvestrant Teva
EMA – Article 57 product data (EU/EEA), 2026-10-28
Medelix receives no money from pharmaceutical companies. Brand names are listed alphabetically and without ranking.
Other substances in the same group
Another question about this substance?
Medelix answers clinical questions from guidelines, studies and product information – every claim with its source.
Sources
- European Medicines Agency. Faslodex – EPAR, Product Information. 2026-10-27. https://www.ema.europa.eu/en/documents/product-information/faslodex-epar-product-information_en.pdf
- EMA – Article 57 product data (EU/EEA), 2026-10-28. https://www.ema.europa.eu/en/human-regulatory-overview/post-authorisation/data-medicines-iso-idmp-standards-post-authorisation/public-data-article-57-database
- EMA – Article 57 product data (EU/EEA), 2026-10-28. https://www.ema.europa.eu/en/human-regulatory-overview/post-authorisation/data-medicines-iso-idmp-standards-post-authorisation/public-data-article-57-database
- TİTCK – Ruhsatlı Beşeri Tıbbi Ürünler Listesi, 2026-10-16. https://www.titck.gov.tr/dinamikmodul/85
- Wikidata (CC0): ATC L02BA.
Editorial: Medelix editorial team · last updated 2026-10-27 · How these pages are made · Report an error
Source: European Medicines Agency (EMA), product information. Not advertising, not a treatment recommendation. For questions about your own treatment, ask your doctor or pharmacist.